Abstract
The allosteric binding sites are usually located in the flexible areas of proteins, which are hardly visible in the crystal structures. However, there are notable exceptions like allosteric sites in receptors in class B and C of GPCRs, which are located within a well-defined bundle of transmembrane helices. Class B and C evolved from class A and even after swapping of orthosteric and allosteric sites the central binding site persisted and it can be used for easy design of allosteric drugs. However, studying the ligand binding to the allosteric sites in the most populated class A of GPCRs is still a challenge, since they are located mostly in unresolved parts of the receptor’s structure, and especially N-terminus. This chapter provides an example of cannabinoid CB1 receptor N-terminal homology modeling, ligand-guided modeling of the allosteric site in GABA receptor, as well as C-linker modeling in the potassium ion channels where the allosteric phospholipid ligand PIP2 is bound.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Motlagh HN, Wrabl JO, Li J et al (2014) The ensemble nature of allostery. Nature 508:331–339. https://doi.org/10.1038/nature13001
Gentry PR, Sexton PM, Christopoulos A (2015) Novel allosteric modulators of G protein-coupled receptors. J Biol Chem 290:19478–19488. https://doi.org/10.1074/jbc.R115.662759
Conn PJ, Christopoulos A, Lindsley CW (2009) Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov 8:41–54. https://doi.org/10.1038/nrd2760
Brogi S, Tafi A, Desaubry L et al (2014) Discovery of GPCR ligands for probing signal transduction pathways. Front Pharmacol 5:255. https://doi.org/10.3389/fphar.2014.00255
Christopoulos A, Changeux JP, Catterall WA et al (2014) International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands. Pharmacol Rev 66:918–947. https://doi.org/10.1124/pr.114.008862
Stasiulewicz A, Znajdek K, Grudzien M et al (2020) A guide to targeting the endocannabinoid system in drug design. Int J Mol Sci 21:2778. https://doi.org/10.3390/ijms21082778
Howlett AC, Breivogel CS, Childers SR et al (2004) Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47(Suppl 1):345–358. https://doi.org/10.1016/j.neuropharm.2004.07.030
Salmaso V, Jacobson KA (2020) In Silico drug design for Purinergic GPCRs: overview on molecular dynamics applied to adenosine and P2Y receptors. Biomolecules 10:812. https://doi.org/10.3390/biom10060812
Deganutti G, Cuzzolin A, Ciancetta A et al (2015) Understanding allosteric interactions in G protein-coupled receptors using Supervised Molecular Dynamics: a prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000. Bioorg Med Chem 23:4065–4071. https://doi.org/10.1016/j.bmc.2015.03.039
Jakowiecki J, Abel R, Orzel U et al (2021) Allosteric modulation of the CB1 cannabinoid receptor by Cannabidiol-A molecular modeling study of the N-terminal domain and the allosteric-Orthosteric coupling. Molecules 26:2456. https://doi.org/10.3390/molecules26092456
Krieger E, Vriend G (2015) New ways to boost molecular dynamics simulations. J Comput Chem 36:996–1007. https://doi.org/10.1002/jcc.23899
Mandell DJ, Coutsias EA, Kortemme T (2009) Sub-angstrom accuracy in protein loop reconstruction by robotics-inspired conformational sampling. Nat Methods 6:551–552. https://doi.org/10.1038/nmeth0809-551
Salomon-Ferrer R, Case DA, Walker RC (2013) An overview of the Amber biomolecular simulation package. WIREs Comput Mol Sci 3:198–210. https://doi.org/10.1002/wcms.1121
Phillips JC, Hardy DJ, Maia JDC et al (2020) Scalable molecular dynamics on CPU and GPU architectures with NAMD. J Chem Phys 153:044130. https://doi.org/10.1063/5.0014475
Huang J, Rauscher S, Nawrocki G et al (2017) CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods 14:71–73. https://doi.org/10.1038/nmeth.4067
UniProt C (2019) UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res 47:D506–D515. https://doi.org/10.1093/nar/gky1049
Canutescu AA, Dunbrack RL Jr (2003) Cyclic coordinate descent: a robotics algorithm for protein loop closure. Protein Sci 12:963–972. https://doi.org/10.1110/ps.0242703
Jo S, Jiang W (2015) A generic implementation of replica exchange with solute tempering (REST2) algorithm in NAMD for complex biophysical simulations. Comput Phys Commun 197:304–311. https://doi.org/10.1016/j.cpc.2015.08.030
Jo S, Kim T, Iyer VG et al (2008) CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem 29:1859–1865. https://doi.org/10.1002/jcc.20945
Tunyasuvunakool K, Adler J, Wu Z et al (2021) Highly accurate protein structure prediction for the human proteome. Nature 596:590–596. https://doi.org/10.1038/s41586-021-03828-1
Jumper J, Evans R, Pritzel A et al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583–589. https://doi.org/10.1038/s41586-021-03819-2
Freyd T, Warszycki D, Mordalski S et al (2017) Ligand-guided homology modelling of the GABAB2 subunit of the GABAB receptor. PLoS One 12:e0173889. https://doi.org/10.1371/journal.pone.0173889
Evenseth LSM, Gabrielsen M, Sylte I (2020) The GABAB receptor-structure, ligand binding and drug development. Molecules 25:3093. https://doi.org/10.3390/molecules25133093
Mao C, Shen C, Li C et al (2020) Cryo-EM structures of inactive and active GABAB receptor. Cell Res 30:564–573. https://doi.org/10.1038/s41422-020-0350-5
Foster DJ, Conn PJ (2017) Allosteric modulation of GPCRs: new insights and potential utility for treatment of Schizophrenia and other CNS disorders. Neuron 94:431–446. https://doi.org/10.1016/j.neuron.2017.03.016
Webb B, Sali A (2017) Protein structure modeling with MODELLER. Methods Mol Biol 1654:39–54. https://doi.org/10.1007/978-1-4939-7231-9_4
McRobb FM, Capuano B, Crosby IT et al (2010) Homology modeling and docking evaluation of aminergic G protein-coupled receptors. J Chem Inf Model 50:626–637. https://doi.org/10.1021/ci900444q
Toro L, Li M, Zhang Z et al (2014) MaxiK channel and cell signalling. Pflugers Arch 466:875–886. https://doi.org/10.1007/s00424-013-1359-0
Lu R, Alioua A, Kumar Y et al (2006) MaxiK channel partners: physiological impact. J Physiol 570:65–72. https://doi.org/10.1113/jphysiol.2005.098913
Bentzen BH, Olesen SP, Ronn LC et al (2014) BK channel activators and their therapeutic perspectives. Front Physiol 5:389. https://doi.org/10.3389/fphys.2014.00389
Hou S, Heinemann SH, Hoshi T (2009) Modulation of BKCa channel gating by endogenous signaling molecules. Physiology (Bethesda) 24:26–35. https://doi.org/10.1152/physiol.00032.2008
Tang QY, Zhang Z, Meng XY et al (2014) Structural determinants of phosphatidylinositol 4,5-bisphosphate (PIP2) regulation of BK channel activity through the RCK1 Ca2+ coordination site. J Biol Chem 289:18860–18872. https://doi.org/10.1074/jbc.M113.538033
Hansen SB, Tao X, MacKinnon R (2011) Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2. Nature 477:495–498. https://doi.org/10.1038/nature10370
Stansfeld PJ, Hopkinson R, Ashcroft FM et al (2009) PIP(2)-binding site in Kir channels: definition by multiscale biomolecular simulations. Biochemistry 48:10926–10933. https://doi.org/10.1021/bi9013193
Li J, Lu S, Liu Y et al (2015) Identification of the conformational transition pathway in PIP2 opening Kir channels. Sci Rep 5:11289. https://doi.org/10.1038/srep11289
Truchon JF, Bayly CI (2007) Evaluating virtual screening methods: good and bad metrics for the "early recognition" problem. J Chem Inf Model 47:488–508. https://doi.org/10.1021/ci600426e
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Jakowiecki, J., Orzeł, U., Gliździnska, A., Możajew, M., Filipek, S. (2023). Specificities of Protein Homology Modeling for Allosteric Drug Design. In: Filipek, S. (eds) Homology Modeling. Methods in Molecular Biology, vol 2627. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2974-1_19
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2974-1_19
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2973-4
Online ISBN: 978-1-0716-2974-1
eBook Packages: Springer Protocols